NuGen M.D. Submits for FDA Emergency Use Authorization Approval for its Needle-Free Injection Systems

Author's Avatar
Jun 15, 2022

VANCOUVER, BC / ACCESSWIRE / June 15, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD, Financial) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, in collaboration with Unifire Inc., a wholly owned subsidiary of Mission Ready Solutions (TSXV: MRS, OTCQX:MSNVF) submitted on June14th, 2022, an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization ("EUA") of NuGen reusable needle-free jet injector (NFJI) systems. NuGen MD NFJI devices are designed for patients and/or healthcare providers for the delivery of insulin, vaccines (potentially including COVID-19 vaccines), and emergency pharmaceutical injectables.